Category: Antibody Technologies
Antibody Technologies market research reports by DelveInsight
-
Anti-neutrophilic cytoplasmic antibody (ANCA) associated Vasculitis - Epidemiology Forecast - 2032
Anti-neutrophilic cytoplasmic antibody (ANCA) associated Vasculitis - Epidemiology Forecast - 2032 Key Highlights Anti-neutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a heterogeneous group of rare autoimmune conditions. ANCA Associated Vasculitis includes three main diseases, which ... Read More
-
Antibody–drug Conjugates (ADCs) in Oncology- Competitive Landscape - 2023
Antibody–drug Conjugates (ADCs) in Oncology- Competitive Landscape - 2023 DelveInsight’s “Antibody–drug Conjugates (ADCs) Competitive landscape, 2023” report provides comprehensive insights about 30+ companies and 35+ drugs in ADCs. It covers the therapeutics assessment by product type, stage, route ... Read More
-
Birtamimab Emerging Drug Insight and Market Forecast – 2032
Birtamimab Emerging Drug Insight and Market Forecast – 2032 “Birtamimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Birtamimab for AL Amyloidosis in the 7MM. A detailed picture of the Birtamimab for AL Amyloidosis in the 7MM, i.e., United States, EU ... Read More
-
Omburtamab Emerging Drug Insight and Market Forecast – 2032
Omburtamab Emerging Drug Insight and Market Forecast – 2032 “Omburtamab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Omburtamab for Leptomeningeal Metastases in the 7MM. A detailed picture of the Omburtamab for Leptomeningeal Metastases in the 7MM, i ... Read More
-
Antibody-mediated Rejection - Market Insight, Epidemiology And Market Forecast - 2032
Antibody-mediated Rejection - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ""Antibody-Mediated Rejection (AMR) - Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the Antibody-Mediated Rejection, historical and forecasted ... Read More
-
Intravenous Immunoglobulin (IVIG) - Epidemiology Forecast - 2032
DelveInsight's "" Intravenous Immunoglobulin (IVIG) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Intravenous Immunoglobulin (IVIG) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the U ... Read More
-
Antibody Drug Conjugate - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Antibody Drug Conjugate- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Antibody Drug Conjugate, historical and forecasted epidemiology as well as the Antibody Drug Conjugate market trends in the United States, EU5 (Germa ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2022
“ Anti-CD80 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022
“ Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2022
“ Anti-CD19 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD19 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022
“ Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2022
“ Anti-CD28 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
“ Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Anti-CD279 (PD-1) Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2022
“ Anti-CD3 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Graft Versus Host Disease (GvHD)- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Graft Versus Host Disease (GvHD), historical and forecasted epidemiology as well as the Graft Versus Host Disease (GvHD) market trends in th ... Read More
-
CD137 Agonist Antibody - Pipeline Insight, 2022
“ CD137 Agonist Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in CD137 Agonist Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
“ Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Immunoglobulin inhibitors - Pipeline Insight, 2022
“ Immunoglobulin inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Immunoglobulin inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2022
“ Anti-CD52 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2022
“ Anti GM-CSF Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2022
“ Anti-CD33 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026 Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseas ... Read More
-
Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032
DelveInsight's "" Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Graft Versus Host Disease (GvHD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Uni ... Read More
-
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
DelveInsight's "" Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barre Syndrome (GBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
DelveInsight's "" Cytokine Release Syndrome (CRS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cytokine Release Syndrome (CRS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
Research Assistance
